Larry Abensur

Larry Abensur is a declared insider of Biosynex (chief executive), with filings sourced from AMF. Between 16 April 2021 and 27 February 2025, the trades on record add up to 32 filings.

Market trades split into 16 purchases (€737k) and 12 sales (€2.7M). Sales outweigh purchases by €2.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 option exercises. Since January 2025: 7 purchases and 1 sale on the market.

Half of the purchases are above €48k and half below. On 16 out of 16 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 28 February 2025: an open-market purchase of €32k, in Biosynex. Filings reach the AMF feed a median of 7 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.